Everyday Health on MSN
There’s a New Drug for Motion Sickness — the First in 40 Years
The FDA approved the pill Nereus (tradipitant) as a new treatment for vomiting caused by motion sickness, with fewer side ...
Stocktwits on MSN
VNDA stock on track to open at three-year high – FDA clears first new motion sickness drug in decades
Two Phase 3 real-world trials, conducted on boats, showed that NEREUS significantly reduced vomiting compared with placebo. ・Vanda is also advancing Tradipitant in clinical development for ...
MedPage Today on MSN
FDA greenlights first motion sickness drug in more than 40 years
The approval marks the first new drug treatment for motion sickness in over four decades and signifies an advancement in understanding motion sickness mechanisms, the company said ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has ...
Does motion sickness turn you into a green, spewing mess? For plenty of people, the answer is yes. Current remedies may or ...
Tradipitant is a selective human substance P/neurokinin-1 receptor antagonist approved for the prevention of vomiting induced by motion in adults.
What Is Nereus, And Why Does It Matter? Nereus (tradipitant) is a new prescription medicine approved by the FDA to help prevent nausea and vomiting caused by motion (motion sickness) in adults, such ...
Analysts raise price targets for Vanda Pharmaceuticals after FDA approved a motion sickness drug, citing growth potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback